The treatment goals for adolescents include the following:
- Treat inflammation in the airways, usually with daily medication, to prevent asthma attacks
- Use short-acting drugs to treat asthma attacks
- Avoid or minimize the effect of asthma triggers
- Maintain normal activity levels
- Include the adolescent in creating and managing a treatment plan
Your doctor will use a stepwise approach for treating your child's asthma. The goal is overall management with a minimum number of asthma attacks that require short-term treatment.
This means that initially the type or dosage of treatment may be increased until the asthma is stable. When it is stable for a period of time, your doctor may then step down the treatment, so that your child takes the minimum drug treatment needed to remain stable. If your doctor determines at some point that your child is using a short-acting drug too often, the long-term treatment will be stepped up to a higher dose or additional medication.
This stepwise approach may result in changes up or down over time, depending on your child's response to treatment and overall growth and development, as well as on seasonal changes, changes in activity levels, or other factors.
Medications for long-term control
Long-term control, or maintenance, medications are usually taken daily. Discuss with your doctor risks associated with treatment options and learn signs of adverse reactions.
Types of maintenance medication include the following:
- Inhaled corticosteroids are the most common maintenance medications for asthma, as well as the preferred treatment according to the National Asthma Education and Prevention guidelines. These anti-inflammatory drugs include fluticasone (Flovent Diskus, Flovent HFA), budesonide (Pulmicort Flexhaler, Pulmicort Respules), flunisolide (Aerospan), ciclesonide (Alvesco), beclomethasone (Qvar) and mometasone (Asmanex).
- Long-acting beta agonists (LABAs) may be added to inhaled corticosteroid treatment when a corticosteroid alone does not result in stable asthma management. Long-acting beta agonists have been linked to severe or life-threatening asthma attacks. According to current Food and Drug Administration recommendations, LABA medication is given to an adolescent only when the drug is administered in combination with a corticosteroid. These include the combinations fluticasone-salmeterol (Advair Diskus, Advair HFA), budesonide-formoterol (Symbicort) and mometasone-formoterol (Dulera).
- Leukotriene modifiers may be used as an alternative to corticosteroids for mild asthma or added to a treatment plan when an inhaled corticosteroid treatment alone doesn't result in stable asthma management. These include montelukast (Singulair), zafirlukast (Accolate) and zileuton (Zyflo, Zyflo CR). In rare cases, these medications have been linked to psychological reactions such as aggression, anxiousness, hallucinations, depression, irritability and suicidal thinking. Seek medical advice right away if your child has any unusual psychological reaction.
- Theophylline is a daily pill that opens the airways (bronchodilator). Theophylline (Theochron) may be used as an alternative for long-term control of mild asthma or added to a corticosteroid treatment.
- Oral corticosteroids are used only when asthma cannot be controlled with other treatments.
These medications — called short-acting bronchodilators — provide immediate relief of asthma symptoms, and effects last four to six hours. Short-acting bronchodilators for asthma include albuterol (ProAir HFA, Ventolin HFA, others) and levalbuterol (Xopenex HFA).
For adolescents with mild, intermittent asthma symptoms, the short-acting medication may be the only treatment needed.
For adolescents who have persistent asthma and use maintenance drugs, the short-acting drug is used as a quick-relief, or rescue, medication to treat asthma attacks. It may also be used to prevent asthma symptoms triggered by exercise.
Immunotherapy for allergy-induced asthma
Your doctor may recommend allergy shots (immunotherapy) if an allergy induces asthma attacks and if the allergen cannot be avoided. This treatment may be particularly useful for an allergy to pets, dust mites or pollens.
The purpose of allergy shots is to build up a tolerance by gradually increasing exposure to an allergen. Shots are administered once or twice a week in increasing doses, usually for three to six months. A maintenance dose is administered every two to four weeks for a period of three to five years.
Medication delivery devices
Most asthma medications are given with a device that allows a child to breathe medication directly into the lungs. Talk to your doctor about the proper use of a device, the delivery options for your child's medication and the appropriate device for your child's needs. Inhalation devices include:
- Metered dose inhaler. Small hand-held devices, metered dose inhalers are a common delivery method for asthma medication. This device propels the medication in a puff that needs to be inhaled in a single breath. An attachment called a spacer can improve medication delivery. A valved holding chamber is a similar attachment, but allows several regular breaths and doesn't allow accidental exhaling into the device.
- Dry powder inhalers. This hand-held device doesn't propel the medication. A deep, rapid inhalation activates the release of the drug and is necessary to get a full dose.
- Nebulizer. A nebulizer turns medications into a fine mist your child breathes in through a face mask. A nebulizer is a good option for a child who finds it difficult to use other inhalers.
Asthma management with adolescents
Treating asthma requires adherence to an ongoing treatment plan, regular monitoring, adjustments in the plan as needed and self-care. Some studies have shown that asthma management creates a particular set of challenges among adolescents, who are seeking greater autonomy, developing socially and emotionally, and experiencing changes in their relationships with friends and family.
The task of managing a chronic medical condition or taking medication in front of peers may cause embarrassment or self-consciousness. The routine may seem like a burden to greater independence, or there may be denial about the severity of asthma. Adolescents with asthma may be at greater risk of depression and anxiety, and these psychological factors may result in poorer asthma management.
Your child's doctor may address these concerns with several strategies, including the following:
- Assessing for symptoms of depression or anxiety
- Assessing for risk-taking behaviors
- Assessing for proper technique in using medications
- Talking with your child about his or her understanding of the disease and the impact of the medication
- Talking with your child about how he or she feels about taking medication, especially in front of people
- Working with the family to create a plan that gradually shifts more responsibility to your child
Create an action plan
Your doctor can work with you and your adolescent to create a written action plan that outlines self-monitoring and care. You should share the plan with other family members, friends, teachers, coaches and school administrators. A thorough plan includes such things as the following:
- Your child's name and age
- Physician and emergency contact information
- The type, dose and timing of long-term medications
- The type and dose of rescue medication
- A list of common asthma triggers for your child and tips for avoiding them
- A system for rating normal breathing and moderate symptoms and severe symptoms
- Instructions for what to do when symptoms occur and when to use rescue medication
- Instructions for when to seek emergency care
Monitor and record
Your doctor will likely ask your child to use a peak flow meter at home. This hand-held device measures how well air flows from the lungs when exhaling. It can monitor the effectiveness of your ongoing treatment and assess lung function after using a rescue medication.
You can work with your adolescent to keep a record of peak flow measurements, symptoms and treatment schedule to share with your doctor. These records can help your doctor determine if the long-term treatment plan is effective and make adjustments to the plan. Keep appointments as recommended by your doctor to review records and adjust the action plan as necessary.
Information that should be recorded includes:
- Regular, nonattack peak flow measurements as requested by your doctor
- The time, duration and circumstances of an asthma attack
- Treatment responses to asthma attacks, including peak flow measurements
- Peak flow measurements after exercise
- Medication side effects
- Changes in symptoms
- Changes in sleep patterns
Control asthma triggers
Depending on the triggers for your child's asthma, make adjustments as much as possible at home, school and other environments to minimize your child's exposure to triggers. These may include:
Oct. 18, 2016
- Cleaning thoroughly to control dust and pet dander
- Checking pollen count reports
- Removing cleaning products or other household products that may be an irritant
- Using allergy medicine as directed by your child's doctor
- Helping your child develop a strategy for avoiding triggers
See more In-depth
- Bitsko MJ, et al. The adolescent with asthma. Paediatric Respiratory Reviews. 2014;15:146. Accessed Sept. 8, 2016.
- Adkinson NF, et al. Diagnosis of asthma in infants and children. In: Middleton's Allergy: Principles and Practice. 8th ed. Philadelphia, Pa.: Saunders Elsevier; 2014. http://www.clinicalkey.com. Accessed Aug. 3, 2016.
- Expert panel report 3 (EPR3): Guidelines for the diagnosis and management of asthma. Bethesda, Md.: National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/guidelines/asthma/. Accessed Aug. 3, 2016.
- Fanta CH. An overview of asthma management. http://www.uptodate.com/home. Accessed Sept. 8, 2016.
- Questions and answers: New safety requirements for long-acting asthma medications called long-acting beta agonists (LABAs). Food and Drug Administration. http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm200719.htm. Accessed Sept. 12, 2016.
- Updated information on leukotriene inhibitors: Montelukast (marketed as Singulair), zafirlukast (marketed as Accolate), and zileuton (marketed as Zyflo and Zyflo CR). Food and Drug Administration. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm165489.htm. Accessed Sept. 12, 2016.
- Allergy shots (immunotherapy). American Academy of Allergy, Asthma & Immunology. https://www.aaaai.org/conditions-and-treatments/treatments/allergy-shots-(immunotherapy). Accessed Sept. 12, 2016.
- Spacers and valved holding chambers (VHCs) for use with metered dose inhalers (MDIs). American Academy of Allergy, Asthma & Immunology. https://www.aaaai.org/conditions-and-treatments/library/asthma-library/spacers-asthma. Accessed Aug. 4, 2016.
- Inhaled asthma medications. American Academy of Allergy, Asthma & Immunology. https://www.aaaai.org/conditions-and-treatments/library/at-a-glance/inhaled-asthma-medications. Accessed Sept. 12, 2016.
- Sadof M, et al. Adolescent asthma: A developmental approach. Current Opinions in Pediatriacs. 2011;23:373. Accessed Sept. 8, 2016.
- Peak flow meter. American Academy of Allergy, Asthma & Immunology. https://www.aaaai.org/conditions-and-treatments/library/at-a-glance/peak-flow-meter. Accessed Sept. 8, 2016.